Position in INVA
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$10,088,281
-$262,091 QoQ
Shares Held
444,222
0.0% QoQ
Ownership
0.602%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1
of 18 holders
Holding Since
Dec 2020
21 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in INVA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Assenagon Asset Management S.A. holds $1,943,463,989 across 69 Biotechnology names. INVA ranks #31 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
759,564 | $377,298,225 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
8,362,952 | $295,964,871 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
244,927 | $152,721,781 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
454,682 | $111,292,513 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
1,762,086 | $100,826,560 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
997,643 | $78,085,517 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
124,214 | $66,696,707 | |
| 8 | TARS |
Tarsus Pharmaceuticals, Inc.
|
947,495 | $59,635,335 |
All Filings in INVA
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,088,281 | 444,222 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $10,350,372 | 444,222 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $8,879,997 | 444,222 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $8,107,051 | 444,222 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $8,924,419 | 444,222 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $8,053,744 | 444,222 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $7,707,251 | 444,222 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $8,577,926 | 444,222 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $13,287,411 | 810,208 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $12,347,569 | 810,208 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $12,995,736 | 810,208 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $10,524,601 | 810,208 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $10,313,947 | 810,208 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $9,114,840 | 810,208 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $22,695,580 | 1,712,874 | Shares | Sole | 2023-01-12 | |
| 2022-09-30 | $22,093,040 | 1,902,932 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $29,562,715 | 2,002,894 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $21,306,323 | 1,101,102 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $3,079,935 | 178,547 | Shares | Sole | 2022-02-01 | |
| 2021-03-31 | $846,908 | 70,871 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $878,240 | 70,883 | Shares | Sole | 2021-02-01 | |
| No filing history on record for this holder in this stock. | ||||||